Hypertension, Essential: Clinical Trials

3 trials for Hypertension, Essential, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 terminated. 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 13Completed 2, Terminated 1

Follow Hypertension, Essential: new trials by email Literature Review of Hypertension, Essential trials Research Report on Hypertension, Essential

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Cardiovascular Effects of Angiotensin (1-7) in Essential Hypertension
Angiotensin (1-7), Trimethaphan, Phenylephrine - Hypertension, Hypertension, Essential
Phase 1TerminatedVanderbilt University242015-01-012024-01-09
Pivotal Bioequivalence FDC Nifedipine / Candesartan vs. Loose Combination of Single Components, Fed
Nifedipine/Candesartan (BAY 98-7106), Nifedipine (Adalat, BAY A1040) and Candesartan (Atacand, BAY 12-9333) - Hypertension, Essential
Phase 1CompletedBayer492011-04-012015-12-10
Single Dose Bioequivalence Study Comparing Nifedipine/Candesartan FDC (Fixed Dose Combination) With Loose Combination of Nifedipine GITS (Gastro-intestinal Therapeutic System) Plus Candesartan and Single Components Under Fasting Conditions
Nifedipine-candesartan FDC (BAY 98-7106), Nifedipine GITS (Adalat LA, BAYA1040), Candesartan (Atacand) - Hypertension, Essential
Phase 1CompletedBayer492010-11-012015-12-10

Narrower conditions

Essential Hypertension (3)  ·  Hypertension (1)

Broader conditions

Cardiovascular Diseases (3)  ·  Vascular Diseases (3)  ·  Hypertension (2)

Interventions

Nifedipine (2)  ·  candesartan (2)  ·  candesartan cilexetil (2)  ·  Phenylephrine (1)  ·  Trimethaphan (1)  ·  angiotensin I (1-7) (1)  ·  trimethaphan camsylate (1)

Sponsors

Bayer (2)  ·  Vanderbilt University (1)

Countries

Germany (2)  ·  United States (1)

Top investigators

Italo Biaggioni, MD (1)

Results publications

PMID 23849325